The aim of this prospective, double-blind, randomized, placebo-controlled clinical trial [median 7.0, interquartile range (6.0-8.0)] and fentanyl groups [median 7.0, interquartile range (6.0-8.0)]. Both appeared significantly better than the saline group [median 8.0, interquartile range (6.75-9.25 
Propofol is widely used as an induction agent during general anaesthesia. However, when 2.5 mg.kg -1 propofol is used alone in unpremedicated patients it may provide less than satisfactory laryngeal mask airway (LMA) insertion conditions, giving rise to patient gagging, coughing, movement and even laryngospasm 1 . In addition, this dose of propofol may be associated with unacceptable cardiorespiratory instability and depression, especially in the elderly and unfit patients [2] [3] . The addition of opioids (fentanyl, alfentanil), or even muscle relaxants (suxamethonium, mivacurium), have been shown to improve the insertion conditions with an overall success rate of up to 85-95% 4 . Unfortunately these medications increase the incidence and duration of apnoea. While the use of opioids can cause respiratory depression, muscle relaxants also increase the risk of aspiration.
The combination of ketamine and propofol has been shown to be additive at the endpoint of hypnosis and anaesthesia 5 . When used for total intravenous anaesthesia it has superior analgesia with less respiratory depression during the early recovery phase compared with the use of propofol and fentanyl in combination 6 . This may prove to be an advantage for LMA insertions, which require a sufficient depth of anaes-thesia to obtund the airway reflexes to prevent coughing, movement and laryngospasm. Ketamine increases heart rate and arterial blood pressure by its activation of the sympathetic nervous system. When used with propofol for induction of general anaesthesia, the cardiostimulant effects of ketamine balance the cardiodepressant effects of propofol 5, 6 . A previous study has also shown that the use of ketamine in subanaesthetic doses before induction with propofol preserves haemodynamic stability compared with induction with propofol alone during tracheal intubation 7 . However, there have been no previous published reports on the use of ketamine before induction with propofol to facilitate LMA insertion.
The main aim of this study was to compare the effects of ketamine in subanaesthetic doses with fentanyl and saline before induction with propofol on the haemodynamic profile during LMA insertion. The secondary aim was to investigate whether the administration of ketamine before induction with propofol improves LMA insertion conditions.
METHODS
After obtaining institutional research ethics committee approval and written informed consent, 90 ASA 1-2 patients, aged 18 to 60 years, requiring surgery in which an LMA and spontaneously breathing anaesthetic technique was planned were enrolled in a double-blind randomized controlled trial. Patients at risk for aspiration, with a history of allergy to propofol or ketamine, or anticipated difficult airway, or with a history of hypertension, coronary artery disease, or pyschiatric illness were excluded. Using sealed pre-coded envelopes (block randomization of 10 each); patients were randomly allocated into one of the three groups. The ketamine group (n=30) received ketamine 0.5 mg.kg -1 (The dose 0.5 mg.kg -1 was chosen based on a previous study by Furuya et al 7 ) , the fentanyl group (n=30) received fentanyl 1 µg.kg -1 and the saline group (n=30) received 5 ml 0.9% sodium chloride (normal saline). Both ketamine and fentanyl were diluted with 0.9% sodium chloride to 5 ml. The study solution was prepared by a medical officer not involved in the study.
Patients were fasted overnight and received premedication with oral midazolam 0.15 mg.kg -1 one hour before induction of anaesthesia. Baseline measurements of heart rate (HR), mean arterial pressure (MAP), systolic arterial pressure (SAP), diastolic arterial pressure (DAP) and arterial oxygen saturation (SpO 2 ), were recorded in the anaesthetic room. Intravenous access was secured. A peripheral vein was used for drug administration. No fluid loading was required.
After preoxygenation for three minutes, patients were given their assigned study drugs intravenously over 10 s followed immediately by propofol 2.5 mg.kg -1 intravenously over 15 s. If required, further increments of propofol 0.5 mg.kg -1 were given every 30 s until loss of consciousness and loss of eyelash reflex. Insertion of the LMA was performed 60 s after injection of propofol by a blinded investigator using the technique recommended by Brain 8 . All laryngeal mask airway insertions were performed by the same blinded investigator. The same blinded investigator who performed the laryngeal mask insertion also graded the LMA insertion conditions according to mouth opening (1=full, 2=partial, 3= nil), coughing (1=nil, 2=mild, 3=severe), swallowing (1=nil, 2=mild, 3=severe), movement (1=nil, 2= mild, 3=severe), laryngospasm (1=nil, 2=mild, 3= severe) and ease of LMA insertion (1=easy, 2= difficult, 3=impossible). The six scores were then summed to give an overall insertion conditions score.
Following successful insertion, the LMA position was assessed by observing chest expansion and capnography during spontaneous or assisted breathing. The presence of apnoea, defined as absence of respiration for more than 30 s, and the duration of apnoea following LMA insertion was noted. If the first attempt at LMA insertion was unsuccessful or resulted in malposition, the patient received a subsequent bolus dose of propofol 0.5 mg.kg -1 and insertion was attempted again to a maximum of three attempts. The total number of attempts at LMA insertion was recorded. However, the conditions during LMA insertion were only graded at the first attempt.
After successful LMA insertion, anaesthesia was maintained with 1% isoflurane and 66% nitrous oxide in oxygen using a circle absorber system. Throughout induction, all patients were monitored using a pulse oximeter, automated arterial pressure monitor, capnograph and electrocardiograph. (Spacelab Medical, Inc. Redmond, WA, U.S.A.).
MAP, SAP, DAP and heart rate were recorded immediately after induction of anaesthesia, immediately before insertion of LMA, and immediately after LMA insertion, and then every one minute thereafter for up to three minutes. Cardiovascular interventions included metaraminol 0.01 mg/kg IV if the SAP decreased to less than 80 mmHg, and atropine 0.4 mg IV if the HR decreased to less than 45 bpm.
The following day, all patients were specifically asked about hallucinations, nightmares, nausea, vomiting, and sore throat. A power analysis indicated that to detect a 20% change from a mean systolic pressure of 120 mmHg (SD 10 mmHg) 18 patients in each group would be required to detect a 0.05% significant difference with a power of 0.9. Analyses were performed using Statistical Package for Social Science Version 10.0 (SPSS Ltd, Chicago, IL, U.S.A.). Values are presented as mean (SD or range) or number (%) or median (interquartile range). Haemodynamic data were analysed using ANOVA for repeated measurements, followed by Tukey test for multiple comparisons. Ordinal categorical data such as LMA insertion conditions and number of attempts were analysed with Kruskal Wallis test. Nominal categorical data such as gender was analysed with Chi Square test. A P value <0.05 or P<0.05/number of comparisons (Tukey correction) was accepted as statistically significant.
RESULTS
Anaesthesia and surgery were uncomplicated in all 90 patients studied. The three study groups were well matched for age, gender, ASA status, body weight, baseline SAP, MAP, and HR, and total propofol dose administered ( Table 1 ).
The number of attempts at LMA insertion were similar in all groups. Successful insertion and correct positioning of the LMA were similar in all three groups. However the LMA insertion conditions summed scores for the ketamine and fentanyl groups were more favourable when compared with that of the saline group (P=0.024). The number of cases requiring additional propofol for successful insertion was also higher in the saline group 36.7% (11/30) compared with fentanyl 23.3 % (7/30) and ketamine 10 % (3/30) groups (Table 2) .
Systolic blood pressure was significantly higher in the ketamine group compared to the saline (P=0.0001) and the fentanyl (P=0.010) groups.
There was no significant difference between fentanyl and saline (P=0.328) (Figure 1 ).
Changes in heart rate were similar among the three groups ( Figure 2 ).
There Values are mean (SD or range) or number (percentage).
The changes in mean (SD) systolic blood pressure following induction and LMA insertion. Systolic blood pressure was significantly higher in the ketamine groups when compared to both the fentanyl (P=0.010) and saline (P=0.0001) groups. 
DISCUSSION
In the present study we demonstrated consistently higher mean arterial pressure throughout the study period in the ketamine group when compared to the fentanyl and saline groups. Although the changes in the heart rate were not significantly different, there was a trend to a higher HR in the ketamine group. Both ketamine and placebo groups showed an elevation of heart rate from baseline, whereas bradycardia was the feature of fentanyl-propofol combination. The indirect action via the sympathomimetic effect of ketamine on the sinus node may be the mechanism for an increase in heart rate.
Although a decrease in blood pressure is rarely of clinical importance in young and healthy individuals, it is not desirable in elderly patients. Elderly patients are more sensitive to propofol 9 , and hypotension in these patients may critically reduce tissue perfusion and oxygenation.
Ketamine has been used to supplement propofol and midazolam for hypnosis, induction, and maintenance of anaesthesia [5] [6] [7] 10 ; the combinations have been shown to attenuate haemodynamic depression intraoperatively without causing significant respiratory depression. No unpleasant emergence phenomena were reported 5 . Ketamine produces dose-related increases in the rate-pressure product and a transient increase in cardiac index; both peripheral resistance and heart rate are augmented. Propofol decreases arterial pressure in healthy patients by decreasing peripheral vascular resistance and myocardial contractility. Heart rate is frequently slowed, with more significant vagotonic effects with large doses. When used with propofol for induction of general anaesthetic, the cardiostimulant effect of ketamine, even in subanaesthetic doses, may balance the cardiodepressant pressure effects of propofol 7 . Smooth insertion and correct positioning of an LMA requires adequate mouth opening and sufficient depth of anaesthesia to prevent complications such as gagging, coughing, swallowing, head or limb movement and laryngospasm [11] [12] . Coughing occurs occasionally when the LMA touches the epiglottis. Swallowing, gagging and coughing can dislodge a correctly positioned LMA and it may also lead to laryngospasm and airway obstruction. Traumatic LMA insertion also increases postoperative sore throat 13 . Propofol is currently the induction agent of choice for LMA insertion. However, when propofol 2.5 mg.kg -1 is used alone in unpremedicated patients it provides less than satisfactory LMA insertion conditions 1 . This dose is also associated with considerable cardiovascular depression especially in the elderly and unfit patients [2] [3] . With the use of the ketamine in our study, we were able to achieve comparable conditions to fentanyl for LMA insertion following anaesthetic induction with propofol, and significantly better than placebo. The "summed score" of conditions during LMA insertion was significantly better although ketamine and fentanyl did not improve mouth opening, coughing or laryngospasm when compared with propofol alone. Mouth-opening was recorded as non-ideal in nearly half (36.7%-43.3%) of our patients. Despite the nonideal situation, our incidence of difficult insertion was only 3.3% of patients receiving ketamine, compared to 16.7% of patients receiving fentanyl and 26.7% receiving saline. Our incidence of difficult LMA insertion in the ketamine group was lower compared with Cheam et al 4 who reported a 70% incidence of difficult mouth-opening (partial or nil) when co-administering fentanyl 1 µg.kg -1 and a 18% incidence of difficult insertion (difficult or impossible). Although the overall successful insertion and correct position were similar among the three groups, the number of cases that required additional administration of propofol was higher in the saline (37%) group compared to the ketamine (10%) and fentanyl (23%) groups.
In this study we assessed LMA insertion conditions using an unvalidated methodology based on a sixvariable/three-grade score proposed by Silivagam et al 14 and Cheam et al 4 . We were able to use this score to assess both the ease of placement and the patient's response. We graded four fundamental patient responses to LMA insertion: swallowing, coughing, movement and laryngospasm. Swallowing and movement were the responses that we encountered most frequently (Table 2) . Previous studies have shown that for smooth insertion and tolerance of LMA in the hypopharynx the swallowing reflex must be suppressed 13 . If the patient is insufficiently anaesthetized this response will be triggered. Coughing and gagging are more potent reflexes, triggered by irritation of the larynx or epiglottis and preventing foreign material entering the trachea and lungs. The LMA is designed to avoid triggering coughing and gagging because its cuff sits posterior to the larynx in the hypopharynx, as evidenced by the observed low incidence of coughing. The incidence of patient movement was highest in the saline group (50%) with 25% of them having severe movement. The least frequent response was laryngospasm. It is not uncommon for LMA insertion to cause some transient cord closure. Two patients in the fentanyl group developed severe laryngospasm and one patient in the saline group had mild laryngospasm and none in the ketamine group.
We were not able to show any difference in conditions for LMA insertion when comparing the addition of ketamine with that of fentanyl to propofol except that mild movement was more common in the ketamine group. However the use of fentanyl was associated with a greater cardiorespiratory depression compared with ketamine and placebo. Prolonged apnoea occurred more frequently with fentanyl than with ketamine or saline. Our results were comparable to other studies, whereby fentanyl and mivacurium were used to facilitate LMA insertion following propofol induction 4, 13 . Although these studies have shown that fentanyl improves conditions during laryngeal mask airway insertion, it also prolongs the duration of apnoea.
There is no consensus on the criteria to assess LMA insertion conditions. In the current unvalidated intubating LMA score, all the four parameters were allocated equal value. According to the Copenhagen Consensus Conference Criteria 15 on endotracheal intubation, excellent (=1) and good (=2) intubating conditions were considered as clinically "acceptable", whereas the presence of a single quality listed under "poor" (=3) were regarded as clinically "not acceptable".
The summed insertion conditions score in the ketamine and fentanyl groups (7 each) was only slightly lower than the saline group. Moreover, this may not represent a true difference. However, any attempt to improve insertion conditions could be beneficial in patients undergoing eye surgery, and may also reduce the incidence of sore throat. We did not focus on the clinical implication of the scores but our findings may provide baseline data for future studies.
In this study our impression was that emergence phenomenon and postoperative nausea and vomiting was not a problem in these group of patients given ketamine. However a more formal study was needed to confirm this impression.
In conclusion, our study has shown that the addition of ketamine 0.5 mg.kg -1 improves haemodynamics when compared to fentanyl 1 µg.kg -1 , with less prolonged apnoea, and is associated with better LMA insertion conditions than placebo (saline).
